Drugs / vaccine-13vPnC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01432262 | Jul → Dec 2011 | pneumococcal infection | Pfizer | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | vaccine-13vPnC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01432262 ↗ |
| Known as | PCV13 | “This open-label multicenter clinical trial conducted in Mexico assessed the immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) in adults ≥ 50 years...” PMID 25499011 ↗ Dec 2014 |
| Modality | Vaccine | “a 13-valent pneumococcal conjugate vaccine (PCV13)” PMID 25499011 ↗ Dec 2014 |
| Route | Intramuscular | “administered in deltoid muscle of arm” NCT01432262 ↗ |